Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Pain. 2016 Sep;157(9):2024–2032. doi: 10.1097/j.pain.0000000000000608

Figure 3.

Figure 3

(A) Representative western blotting images and quantification of GLT-1 and α-tubulin in the right LC from SNL 2W rats treated with repeated intra-LC injections of control (8.3 pmol/0.5 μl) or GLT-1 (8.3 pmol/0.5 μl) siRNA for 5 days. Data (mean + SD) are presented as ratio to α-tubulin. (B) Control and GLT-1 siRNA treated rats received an intraperitoneal injection of gabapentin (100 mg/kg). Withdrawal thresholds in the right hindpaw were measured prior to (baseline) and one hour after gabapentin. Data (mean + SD) are presented as change from baseline.